| Consensus on diagnosis and management of Cushing's disease: a guideline update M Fleseriu, R Auchus, I Bancos, A Ben-Shlomo, J Bertherat, NR Biermasz, ... The lancet Diabetes & endocrinology 9 (12), 847-875, 2021 | 602 | 2021 |
| European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas G Raverot, P Burman, A McCormack, A Heaney, S Petersenn, V Popovic, ... European journal of endocrinology 178 (1), G1-G24, 2018 | 518 | 2018 |
| Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016 A McCormack, OM Dekkers, S Petersenn, V Popovic, J Trouillas, ... European journal of endocrinology 178 (3), 265-276, 2018 | 265 | 2018 |
| Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status AI McCormack, JAH Wass, AB Grossman European journal of clinical investigation 41 (10), 1133-1148, 2011 | 180 | 2011 |
| Using the ISBAR handover tool in junior medical officer handover: a study in an Australian tertiary hospital JE Thompson, LW Collett, MJ Langbart, NJ Purcell, SM Boyd, ... Postgraduate medical journal 87 (1027), 340-344, 2011 | 169 | 2011 |
| Low O6‐methylguanine‐DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours AI McCormack, KL McDonald, AJ Gill, SJ Clark, MG Burt, KA Campbell, ... Clinical endocrinology 71 (2), 226-233, 2009 | 168 | 2009 |
| Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement S Petersenn, M Fleseriu, FF Casanueva, A Giustina, N Biermasz, ... Nature Reviews Endocrinology 19 (12), 722-740, 2023 | 158 | 2023 |
| European Society of Endocrinology. European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas G Raverot, P Burman, A McCormack, A Heaney, S Petersenn, V Popovic, ... Eur J Endocrinol 178 (1), G1-G24, 2018 | 145 | 2018 |
| Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases M Losa, E Mazza, MR Terreni, A McCormack, AJ Gill, M Motta, MG Cangi, ... European Journal of Endocrinology 163 (6), 843-851, 2010 | 111 | 2010 |
| Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement MCS Boguszewski, CL Boguszewski, W Chemaitilly, LE Cohen, ... European Journal of Endocrinology 186 (6), P35-P52, 2022 | 92 | 2022 |
| Impulse control disorders in dopamine agonist-treated hyperprolactinemia: prevalence and risk factors SMC De Sousa, J Baranoff, RL Rushworth, J Butler, J Sorbello, J Vorster, ... The Journal of Clinical Endocrinology & Metabolism 105 (3), e108-e118, 2020 | 77 | 2020 |
| Outcomes of pituitary surgery for Cushing’s disease: a systematic review and meta-analysis A Stroud, P Dhaliwal, R Alvarado, MJ Winder, BP Jonker, JW Grayson, ... Pituitary 23 (5), 595-609, 2020 | 76 | 2020 |
| Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic—an international perspective M Fleseriu, M Buchfelder, JS Cetas, PK Fazeli, SM Mallea-Gil, M Gurnell, ... Pituitary 23 (4), 327-337, 2020 | 71 | 2020 |
| Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients P Burman, J Trouillas, M Losa, A McCormack, S Petersenn, V Popovic, ... European journal of endocrinology 187 (4), 593-605, 2022 | 67 | 2022 |
| Aggressive pituitary tumours and carcinomas: two sides of the same coin? J Trouillas, P Burman, A McCormack, S Petersenn, V Popovic, O Dekkers, ... European journal of endocrinology 178 (6), C7-C9, 2018 | 65 | 2018 |
| MANAGEMENT OF ENDOCRINE DISEASE: Does gender matter in the management of acromegaly? NF Lenders, AI McCormack, KKY Ho European Journal of Endocrinology 182 (5), R67-R82, 2020 | 63 | 2020 |
| Are aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinician’s questions J Trouillas, ML Jaffrain-Rea, A Vasiljevic, O Dekkers, V Popovic, ... Reviews in Endocrine and Metabolic Disorders 21, 243-251, 2020 | 56 | 2020 |
| Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus H Arima, T Cheetham, M Christ-Crain, D Cooper, M Gurnell, ... Endocrine Connections 11 (11), 2022 | 55 | 2022 |
| Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma) N Lenders, A McCormack Pituitary 21 (2), 217-229, 2018 | 48 | 2018 |
| Pituitary hyperplasia: case series and literature review of an under-recognised and heterogeneous condition SMC De Sousa, P Earls, AI McCormack Endocrinology, diabetes & metabolism case reports 2015 (1), 2015 | 48 | 2015 |
